| 1. | catalystcrusin | |
| 2. | 48ncrebs | |
| 3. | blueauger497 | |
| 4. | 2017rogerthat |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | 48ncrebs 10/07/2017 Downgrade in future? |
| 2. | 2017rogerthat 07/25/2018 Sees FY18 revs of $2.9-3.0 bln vs. $2.79 bln |
| 3. | 48ncrebs 07/10/2018 These Top stocks Are In Or Near Buy Range Amid New Stock Market Strength |
| 4. | blueauger497 02/01/2018 needs news - Barclays |
| 5. | 48ncrebs 06/18/2018 Announces that IRKAMBI to treat the underlying cause of cystic fibrosis (CF) |
| 6. | catalystcrusin 01/31/2018 Maxim Group reiterates Buy rating, $195 PT |
| 7. | catalystcrusin 01/23/2018 Breakout day #2 |
| 8. | catalystcrusin 02/12/2018 NEWS sounds good - Announces FDA approval of FDA SYMDEKO |
| 9. | catalystcrusin 10/07/2017 Dont really care what they say, for the more part they only care about themselves. |
| 10. | catalystcrusin 02/05/2018 Beats EPS estimates by $0.07 and beats on revenues |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Vertex Pharmaceuticals Incorporated
- VRTX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.